» Articles » PMID: 26248876

The Current Role of Orthoses in Treating Haemophilic Arthropathy

Overview
Journal Haemophilia
Specialty Hematology
Date 2015 Aug 8
PMID 26248876
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Haemophilic arthropathy (HA) is an inevitable consequence of repeated haemarthroses in people with haemophilia, and principally affects their ankles, knees and elbows. It is advisable that haematological treatment be complemented with rehabilitation therapy and surgery. Orthoses are devices that are used within the framework of rehabilitation, in order to change the functional or structural characteristics of the neuromusculoskeletal system.

Materials And Methods: This article reviews the design, the materials and characteristics of orthoses and the indications for the various orthoses used in HA. Ankle, knee, elbow orthoses, insoles, footwear modifications and orthopedic shoes are discussed.

Results: Orthoses can control or prevent joint movement, stabilise a specific joint or relieve the load or stress on it. These devices must be prescribed by a physician within the framework of rehabilitation. Recommendations for the proper selection and use of orthoses are highly complex.

Discussion: To maximise the benefits of this mode of therapy, a profound understanding of anatomy and biomechanics is crucial, as is an understanding of the devices available for the various joints that may be affected by HA (ankles-feet, knees, elbows).

Conclusions: Orthotic devices can reduce pain and improve quality of life of people with HA, delaying surgery in many cases.

Citing Articles

A systematic review and narrative synthesis of footwear and orthotic devices used in the management of ankle haemarthrosis and haemarthropathy in haemophilia.

Wilkins R, Chapman L, Emmel J, Flannery T, Chapman G, Walwyn R Haemophilia. 2022; 28(3):422-436.

PMID: 35245413 PMC: 9310701. DOI: 10.1111/hae.14521.


Ankle hemophilic arthropathy: literature review.

Greco T, Polichetti C, Cannella A, La Vergata V, Maccauro G, Perisano C Am J Blood Res. 2021; 11(3):206-216.

PMID: 34322283 PMC: 8303020.